Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 621

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications

D'Souza, Anisha A., Devarajan, Padma V. · 2015 · Journal of Controlled Release

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2015.02.022

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 62

  1. Dodeur, 1982, Effects of streptozotocin-induced diabetes mellitus on the binding and uptake of asialoorosomucoid by isolated hepatocytes from rats, Eur. J. Biochem., 123, 383, 10.1111/j.1432-1033.1982.tb19780.x · doi:10.1111/j.1432-1033.1982.tb19780.x
  2. Kawakami, 2002, Glycosylated cationic liposomes for cell-selective gene delivery, Crit. Rev. Ther. Drug Carrier Syst., 19, 171, 10.1615/CritRevTherDrugCarrierSyst.v19.i2.30 · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.30
  3. Wong, 1987, Synthesis of D-galactosamine derivatives and binding studies using isolated rat hepatocytes, Carbohydr. Res., 170, 27, 10.1016/0008-6215(87)85003-6 · doi:10.1016/0008-6215(87)85003-6
  4. Lee, 2011, New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes, Bioorg. Med. Chem., 19, 2494, 10.1016/j.bmc.2011.03.027 · doi:10.1016/j.bmc.2011.03.027
  5. McAbee, 1999, Copper and zinc ions differentially block asialoglycoprotein receptor-mediated endocytosis in isolated rat hepatocytes, J. Biol. Chem., 274, 14750, 10.1074/jbc.274.21.14750 · doi:10.1074/jbc.274.21.14750
  6. Kim, 2006, Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan, Nucl. Med. Biol., 33, 529, 10.1016/j.nucmedbio.2006.03.005 · doi:10.1016/j.nucmedbio.2006.03.005
  7. Debanne, 1982, Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver, Nature, 298, 398, 10.1038/298398a0 · doi:10.1038/298398a0
  8. Fiume, 1997, Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-ʟ-lysine. Synthesis of the carrier and pharmacological properties of the conjugate, J. Hepatol., 26, 253, 10.1016/S0168-8278(97)80038-4 · doi:10.1016/s0168-8278(97)80038-4
  9. Regoeczi, 1978, Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism, Biochim. Biophys. Acta, 541, 372, 10.1016/0304-4165(78)90196-4 · doi:10.1016/0304-4165(78)90196-4
  10. Kaneo, 2000, Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats, Int. J. Pharm., 201, 59, 10.1016/S0378-5173(00)00405-1 · doi:10.1016/s0378-5173(00)00405-1
  11. Bertoldo, 2004, Cloning, sequencing, and characterization of a heat- and alkali-stable type I pullulanase from Anaerobranca gottschalkii, Appl. Environ. Microbiol., 70, 3407, 10.1128/AEM.70.6.3407-3416.2004 · doi:10.1128/aem.70.6.3407-3416.2004
  12. Gupta, 2004, In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system, J. Pharm. Pharm. Sci., 7, 38
  13. Tanaka, 2005, Uptake of pullulan in cultured rat liver parenchymal cells, Biol. Pharm. Bull., 28, 560, 10.1248/bpb.28.560 · doi:10.1248/bpb.28.560
  14. San Juan, 2007, Cationized pullulan 3D matrices as new materials for gene transfer, J. Biomed. Mater. Res. A, 82, 354, 10.1002/jbm.a.31062 · doi:10.1002/jbm.a.31062
  15. Yim, 2011, The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI, Biomaterials, 32, 5187, 10.1016/j.biomaterials.2011.03.069 · doi:10.1016/j.biomaterials.2011.03.069
  16. Shimizu, 1997, Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting, Biol. Pharm. Bull., 20, 881, 10.1248/bpb.20.881 · doi:10.1248/bpb.20.881
  17. Ghiamkazemi, 2010, Synthesis, and characterization, and evaluation of cellular effects of the FOL-PEG-g-PEI-GAL nanoparticles as a potential non-viral vector for gene delivery, J. Nanomater., 10
  18. Meng, 2005, Immobilization of lactobionic acid on polyurethane films and their interaction with hepatocytes, Macromol. Res., 13, 257, 10.1007/BF03219061 · doi:10.1007/bf03219061
  19. Qin, 2011, Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers, Bioconjug. Chem., 22, 1503, 10.1021/bc100525y · doi:10.1021/bc100525y
  20. Shigeta, 2007, Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells, J. Control. Release, 118, 262, 10.1016/j.jconrel.2006.12.019 · doi:10.1016/j.jconrel.2006.12.019
  21. Suginoshita, 2002, Liver targeting of human interferon-beta with pullulan based on metal coordination, J. Control. Release, 83, 75, 10.1016/S0168-3659(02)00197-9 · doi:10.1016/s0168-3659(02)00197-9
  22. Di Stefano, 2000, Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-ʟ-lysine coupling: implications for regional chemotherapy of hepatic micrometastases, Biochem. Pharmacol., 59, 301, 10.1016/S0006-2952(99)00327-5 · doi:10.1016/s0006-2952(99)00327-5
  23. Peng, 2007, Inhibition of hepatocarcinoma by systemic delivery of apoptin gene via the hepatic asialoglycoprotein receptor, Cancer Gene Ther., 14, 66, 10.1038/sj.cgt.7700985 · doi:10.1038/sj.cgt.7700985
  24. Tomiya, 2013, Liver-targeting of primaquine-(poly-gamma-glutamic acid) and its degradation in rat hepatocytes, Bioorg. Med. Chem., 21, 5275, 10.1016/j.bmc.2013.06.028 · doi:10.1016/j.bmc.2013.06.028
  25. Fiume, 1984, Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver, Gut, 25, 1392, 10.1136/gut.25.12.1392 · doi:10.1136/gut.25.12.1392
  26. Naicker, 2014, PEGylated galactosylated cationic liposomes for hepatocytic gene delivery, Colloids Surf. B: Biointerfaces, 122, 482, 10.1016/j.colsurfb.2014.07.010 · doi:10.1016/j.colsurfb.2014.07.010
  27. Weigel, 1980, Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes, J. Biol. Chem., 255, 6111, 10.1016/S0021-9258(18)43708-8 · doi:10.1016/s0021-9258(18)43708-8
  28. Kawakami, 2001, Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs, J. Pharm. Sci., 90, 105, 10.1002/1520-6017(200102)90:2<105::AID-JPS1>3.0.CO;2-1 · doi:10.1002/1520-6017(200102)90:2<105::aid-jps1>3.0.co;2-1
  29. Hara, 1996, Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes, Biochim. Biophys. Acta, 1278, 51, 10.1016/0005-2736(95)00205-7 · doi:10.1016/0005-2736(95)00205-7
  30. Tep, 2009, Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand, J. Liposome Res., 19, 287, 10.3109/08982100902838682 · doi:10.3109/08982100902838682
  31. Hai, 2010, Synthesis of multivalent galactosides as targeting ligand for gene delivery, Synth. Commun., 40, 1802, 10.1080/00397910903161827 · doi:10.1080/00397910903161827
  32. Narainpersad, 2012, Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2, Nucleosides Nucleotides Nucleic Acids, 31, 206, 10.1080/15257770.2011.649331 · doi:10.1080/15257770.2011.649331
  33. Sun, 2005, Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD), J. Drug Target., 13, 121, 10.1080/10611860400024714 · doi:10.1080/10611860400024714
  34. Zhu, 2013, Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate, Int. J. Mol. Sci., 14, 15755, 10.3390/ijms140815755 · doi:10.3390/ijms140815755
  35. Jain, 2010, Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin, AAPS PharmSciTech, 11, 686, 10.1208/s12249-010-9422-z · doi:10.1208/s12249-010-9422-z
  36. Varshosaz, 2012, Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma, J. Liposome Res., 22, 224, 10.3109/08982104.2012.662653 · doi:10.3109/08982104.2012.662653
  37. Lu, 2008, The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice, Int. J. Biol. Macromol., 43, 320, 10.1016/j.ijbiomac.2008.06.006 · doi:10.1016/j.ijbiomac.2008.06.006
  38. Joshi, 2014, Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand, Drug Deliv. Transl. Res., 4, 353, 10.1007/s13346-014-0200-4 · doi:10.1007/s13346-014-0200-4
  39. Managit, 2005, Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells, Int. J. Pharm., 301, 255, 10.1016/j.ijpharm.2005.05.020 · doi:10.1016/j.ijpharm.2005.05.020
  40. Hattori, 2000, Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting, J. Control. Release, 69, 369, 10.1016/S0168-3659(00)00338-2 · doi:10.1016/s0168-3659(00)00338-2
  41. Ishida, 2004, Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice, Pharm. Res., 21, 932, 10.1023/B:PHAM.0000029280.39882.ff · doi:10.1023/b:pham.0000029280.39882.ff
  42. Motoyama, 2011, In vitro gene delivery mediated by lactosylated dendrimer (generation 3, G3)/α-cyclodextrin conjugates into hepatocytes, J. Incl. Phenom. Macrocycl. Chem., 70, 333, 10.1007/s10847-010-9842-0 · doi:10.1007/s10847-010-9842-0
  43. Wang, 2009, Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon, Hepatology, 50, 815, 10.1002/hep.23060 · doi:10.1002/hep.23060
  44. Hohokabe, 2007, Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice, J. Biomed. Nanotechnol., 3, 277, 10.1166/jbn.2007.034 · doi:10.1166/jbn.2007.034
  45. Hwang, 1999, Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT, J. Nucl. Med., 40, 1644
  46. Iimuro, 2010, Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters, J. Hepatobiliary Pancreat. Sci., 17, 673, 10.1007/s00534-010-0264-6 · doi:10.1007/s00534-010-0264-6
  47. Kaibori, 2011, Usefulness of Tc-99m-GSA scintigraphy for liver surgery, Ann. Nucl. Med., 25, 593, 10.1007/s12149-011-0520-0 · doi:10.1007/s12149-011-0520-0
  48. Haubner, 2013, Development of (6)(8)Ga-labelled DTPA galactosyl human serum albumin for liver function imaging, Eur. J. Nucl. Med. Mol. Imaging, 40, 1245, 10.1007/s00259-013-2397-8 · doi:10.1007/s00259-013-2397-8
  49. Yoshinori, 2010, Molecular imaging contrast media for visualization of liver function, Magn. Reson. Imaging, 28, 708, 10.1016/j.mri.2010.02.003 · doi:10.1016/j.mri.2010.02.003
  50. Deal, 1998, Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver, Nucl. Med. Biol., 25, 379, 10.1016/S0969-8051(97)00222-9 · doi:10.1016/s0969-8051(97)00222-9
  51. Ogawara, 1998, Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver, J. Control. Release, 50, 309, 10.1016/S0168-3659(97)00157-0 · doi:10.1016/s0168-3659(97)00157-0
  52. Ha-Kawa, 1997, Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study, Eur. J. Nucl. Med., 24, 130, 10.1007/BF02439544 · doi:10.1007/bf02439544
  53. Yang, 2013, The preparation of 99mTc-DTPA-LSA and its instant lyophilized kit for hepatic receptor imaging, Appl. Radiat. Isot., 74, 1, 10.1016/j.apradiso.2012.12.009 · doi:10.1016/j.apradiso.2012.12.009
  54. Richard, 2009, Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging, Int. J. Pharm., 379, 301, 10.1016/j.ijpharm.2009.05.045 · doi:10.1016/j.ijpharm.2009.05.045
  55. Ketkar-Atre, 2014, In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes, Biomaterials, 35, 1015, 10.1016/j.biomaterials.2013.10.029 · doi:10.1016/j.biomaterials.2013.10.029
  56. Hausdorf, 2009, Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—revival of a disease-activity marker in autoimmune hepatitis, Clin. Chim. Acta, 408, 19, 10.1016/j.cca.2009.06.035 · doi:10.1016/j.cca.2009.06.035
  57. Ise, 2001, Separation of mouse hepatocytes of distinct biological phenotypes based on their asialoglycoprotein receptor-mediated adhesion to an artificial ligand, J. Artif. Organs, 4, 342, 10.1007/BF02480029 · doi:10.1007/bf02480029
  58. Yura, 2009, Coatings of low-density lipoprotein and synthetic glycoconjugates as substrata for hepatocytes, Artif. Organs, 33, 419, 10.1111/j.1525-1594.2009.00746.x · doi:10.1111/j.1525-1594.2009.00746.x
  59. Chernyy, 2013, Surface grafted glycopolymer brushes to enhance selective adhesion of HepG2 cells, J. Colloid Interface Sci., 404, 207, 10.1016/j.jcis.2013.04.025 · doi:10.1016/j.jcis.2013.04.025
  60. Matsuzaki, 1997, Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve, Hepatology, 25, 828, 10.1002/hep.510250407 · doi:10.1002/hep.510250407
  61. DiStefano, 2006, Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas, Dig. Liver Dis., 38, 2
  62. Dong, 2008, Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo, J. Biomed. Mater. Res. A, 84, 777, 10.1002/jbm.a.31328 · doi:10.1002/jbm.a.31328

Cited by

See all 621

Metadata

Authors
D'Souza, A. A., & Devarajan, P. V.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2015-04
Volume
203
Pages
126-139
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2052108548
Cited by
621
References
183
FWCI
10.02
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.